all report title image

Phosphatidylserine Market Analysis & Forecast: 2026-2033

Phosphatidylserine Market, By Nature (Organic and Conventional), By Source (Meat, Fish, and Plants), By Forms (Powder, Liquid, and Capsule), By Distribution Channel (Online and Offline), By Application (Functional Food, Medical Food, Dietary Supplements, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In : 11 Mar, 2026
  • Code : CMI5014
  • Page number :151
  • Formats :
      Excel and PDF :
  • Industry : Pharmaceutical
  • Historical Range : 2020 - 2024
  • Forecast Period : 2026 - 2033

Phosphatidylserine Market Size and Share Analysis - 2026 to 2033

The phosphatidylserine market was valued at USD 178.4 Mn in 2026 and is forecast to reach a value of USD 271.8 Mn by 2033 at a CAGR of 6.5% between 2026 and 2033.

Key Takeaways

  • Based on nature, the conventional segment is expected to hold 68% share of the market in 2026.
  • Based on source, the plants segment is projected to account for 72.8% share of the market in 2026.
  • Based on forms, the powder segment is expected to lead the market with 66.4% share in 2026.
  • Based on distribution channel, the offline segment is projected to capture 76.4% share in 2026.
  • Based on application, the functional food segment is projected to capture 40% share in 2026.
  • Based on Region, Asia Pacific is set to lead the phosphatidylserine market with 45.7% share in 2026. While, North America is anticipated to have the fastest growing region.

Market Overview

Phosphatidylserine is a neutral oil and fatty acid produced in low purity that has an off-flavor to it. Phosphatidylserine is purified by using various purification processes such as ultrafiltration, supercritical CO2 extraction, and solvent extraction. After the purification, phosphatidylserine is utilized in the functional food segment, nutraceuticals, dietary supplements, and other industries. Growing demand for nutritional and fortifying food additives is expected to boost the global phosphatidylserine market during the forecast period. Food and beverage manufacturers are deploying fortification of nutritional additives such as omega-3 fatty acids, fibers, vitamins, minerals, and others in their product offerings.

Current Events and Their Impacts on the Phosphatidylserine Market

Current Event

Description and its Impact

Growth of Cognitive Wellness Market

  • Description: Rising consumer focus on memory, focus, and overall brain health.
  • Impact: Increases demand for PS supplements as a natural cognitive support.
  • Description: Aging populations in the U.S., Japan, and China.
  • Impact: Drives higher adoption of brain health products, making PS a preferred supplement for seniors.
  • Description: Media and public campaigns on mental health and preventive care.
  • Impact: Improves public awareness, boosting willingness to try cognitive supplements, expanding market penetration.

Innovations in PS Formulations and Delivery

  • Description: Launch of sunflower-derived PS (SunPS®) by ECA Healthcare.
  • Impact: Offers allergen-free, plant-based PS, attracting health-conscious consumers and expanding product lines.
  • Description: Advances in liposome technology for better nutrient absorption (e.g., LIPOID liposomes).
  • Impact: Improves bioavailability of PS, enhancing efficacy and consumer adoption.
  • Description: Development of high-concentration, free-flowing powders for supplements and functional foods.
  • Impact: Facilitates easier manufacturing and formulation, increasing product availability in the market.

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Segmental Insights 

Phosphatidylserine Market By Nature

To learn more about this report, Download Free Sample

Phosphatidylserine Market Insights, By Nature: conventional represent the largest market share, due to conventional PS’s established production methods

In terms of nature, the conventional segment is expected to lead the market with 68% share in 2026, owing to its well-established manufacturing infrastructure, cost-effectiveness, and widespread availability across global supply chains. Primarily, the dominance of the Conventional segment can be attributed to its widespread availability, cost-effectiveness, and deep-rooted presence within pharmaceutical and nutraceutical supply chains. Conventional phosphatidylserine is predominantly derived from bovine sources, such as cow brain extracts, and soy lecithin, which have been legally and industrially recognized for decades.

Moreover, the accessibility and cost advantage of conventional phosphatidylserine play a pivotal role in maintaining its market leadership. The established agricultural infrastructure for soy cultivation, notably in countries like the United States, Brazil, and Argentina, sustains a steady and scalable supply of the raw materials necessary for phosphatidylserine extraction.

Phosphatidylserine Market Insights, By Source: Plants dominate the market

In terms of source, the plants segment is expected to hold 68% share of the market in 2026. The plant-based segment has seen robust adoption largely because of the rising global trend toward plant-based diets and vegan-friendly supplements.

For instance, the Veganuary campaign reported that approximately 25.8 million people worldwide participated in Veganuary in January 2025, reflecting the growing consumer shift toward plant-based lifestyles.

Phosphatidylserine Market Insights, By Forms, Powder acquires the most prominent share

In terms of forms, the powder segment is projected to account for 72.8% share of the market in 2026. Owing to its broad applicability, ease of integration into various product formulations, and well-established use across diverse industries including dietary supplements, functional foods, and pharmaceuticals. Powder form of phosphatidylserine is particularly favored for its stability, longer shelf life, and cost-effectiveness in large-scale manufacturing.

For instance, in July 2025, Golden Key Ingredients has launched PSgold, a phosphatidylserine product made from sunflower. Derived from sunflowers, PS comes in a powdered form and can be used in capsules, tablets, and powdered mix formulations. Their PSgold 50F product contains no more than 50% PhosphatidylSerine.

Phosphatidylserine Market Insights, By Distribution Channel: offline dominate the market

In terms of distribution channel, the offline segment is projected to capture 76.4% share in 2026, offline channels encompass pharmacies, health and wellness stores, specialty nutrition outlets, supermarkets, and other brick-and-mortar establishments. These venues have long been the first point of contact for consumers seeking dietary supplements such as phosphatidylserine, largely because of the tangible, experiential nature of shopping in physical stores, where consumers can consult with knowledgeable staff, receive immediate product access, and rely on trusted local providers.

Phosphatidylserine Market Insights, By Application: Functional Food dominate the market

In terms of application, the functional food segment is projected to capture 40% share in 2026, largely driven by increasing consumer awareness about brain health and cognitive function, as well as a growing preference for natural and health-enhancing ingredients in everyday diet. Functional foods, which are foods fortified with additional health-promoting ingredients, have witnessed significant traction as they provide consumers with the dual advantage of nutrition and therapeutic benefits without the need for separate medication.

For instance, in the U.S., people bought USD 92.1 billion worth of functional foods and drinks in 2023. This is expected to grow to USD 106.9 billion by 2026, according to Nutrition Business Journal.

Regional Insights 

Phosphatidylserine Market By Regional Insights

To learn more about this report, Download Free Sample

Asia Pacific Phosphatidylserine Market Analysis & Trends

Asia Pacific is expected to dominate the Phosphatidylserine market with 45.7% share in 2026. The region’s large and aging population, particularly in countries like China, Japan, and India, drives substantial demand for nootropic and cognitive enhancement supplements, as older adults increasingly seek products that support memory, focus, and overall brain health. Rapid urbanization, rising disposable incomes, and growing health awareness among middle-aged and senior populations further fuel the adoption of such supplements.

For instance, per the WHO October 2025 report, while population ageing initially began in high-income countries (for example, in Japan, 30% of the population is already over 60 years old), it is now low- and middle-income countries that are experiencing the greatest change. By 2050, 80% of older people will be living in low- and middle-income countries, meaning that two-thirds of the world’s population over 60 years will live in these countries. This demographic shift highlights the strong future growth potential for brain health products, including phosphatidylserine, in the Asia Pacific region.

North America Phosphatidylserine Market Analysis & Trends

North America is expected to exhibit the fastest growth, driven by cross-border trade, multinational investments, and significant inter-regional research collaborations focusing on cognitive health supplements. The region’s growth is further supported by increasing consumer awareness of age-related cognitive decline, rising demand for nootropic and brain health products, and well-established regulatory and distribution frameworks that facilitate product commercialization.

For instance, the region’s strong innovation ecosystem is reflected in recent developments such as the April 2025 clinical study by SD Head USA, in partnership with Shankar Nutricon, which demonstrated that Actiserine, a next-generation phosphatidylserine ingredient, offers superior bioavailability compared with conventional PS supplements. Such advancements underscore North America’s position as a hub for product innovation, with its research and technology spillover contributing to market growth in other regions, including Asia Pacific.

Phosphatidylserine Market Outlook Country-Wise

The Japan Phosphatidylserine Market Trends

Japan dominates the Asia Pacific phosphatidylserine market, owing to its well-established nutraceutical industry, high consumer awareness regarding cognitive health, and a large aging population that prioritizes brain health supplements.

For instance, with 80% of people satisfied with the availability of quality healthcare (OECD, 2025), consumers are more likely to adopt preventive health products, including phosphatidylserine, further supporting market growth. Government policies and subsidies promoting healthy aging also catalyze the widespread use of dietary supplements.

U.S. Phosphatidylserine Market Trends

The U.S. contributes the highest share in the phosphatidylserine market owing to its well-established pharmaceutical and nutraceutical industries, advanced healthcare infrastructure, and extensive consumer awareness regarding brain health and cognitive enhancement.

As per the National Institutes of Health (NIH), an estimated 7.2 million Americans aged 65 and older currently live with Alzheimer’s dementia, a number projected to rise to 13.8 million by 2060. The substantial prevalence of age-related cognitive decline highlights the growing demand for non-pharmacological interventions and cognitive health supplements, such as phosphatidylserine, among the aging U.S. population.

Market Report Scope 

Phosphatidylserine Market Report Coverage

Report Coverage Details
Base Year: 2025 Market Size in 2026: USD 178.4 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 6.5% 2033 Value Projection: USD 271.8 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Nature: Organic and Conventional
  • By Source: Meat, Fish, and Plants
  • By Forms: Powder, Liquid, and Capsule
  • By Distribution Channel: Online and Offline
  • By Application: Functional Food, Medical Food, Dietary Supplements, and Others
Companies covered:

Solgar Inc., Nature’s Way Products Llc., Wuhan Demekai biotechnology Co. ltd., Jarrow Formulas Inc, Lipoid Gmbh, Lipogen Products Ltd., Double Wood Llc., Xi’an Sino Herb Bio-Technology Co. Ltd., Xian Natural Field Bio- Technique Co. Ltd., N J Chsoyue Pharm Co. Ltd., Swanson Health Products Inc., ECA Healthcare Inc., and IvoVital Gmbh.  

Growth Drivers:
  • Increasing demand for functional foods
  • Increasing popularity of dietary supplements
Restraints & Challenges:
  • Less adoption rate of phosphatidylserine and growing usage of counterfeit products

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Phosphatidylserine Market Driver

Growing demand for cognitive health supplements

The rising global emphasis on cognitive health, particularly amidst aging populations and increasing mental health awareness, is significantly propelling the demand for cognitive health supplements such as phosphatidylserine. Phosphatidylserine, a phospholipid critical for brain cell structure and function, is gaining traction as a natural supplement to enhance memory, cognitive performance, and overall brain health.

Increasing geriatric population worldwide

The increasing geriatric population worldwide is a significant driver propelling the growth of the phosphatidylserine market. Phosphatidylserine, a phospholipid crucial for cognitive function, increasingly appeals to older adults seeking to combat age-related cognitive decline, memory loss, and neurodegenerative conditions such as Alzheimer’s disease. Recent trends indicate that there is an increasing awareness and acceptance of preventive healthcare among older adults, with many seeking non-pharmaceutical options to manage cognitive decline.

Phosphatidylserine Market Opportunity

Development of plant-based and vegan phosphatidylserine alternatives

The development of plant-based and vegan phosphatidylserine (PS) alternatives is significantly reshaping the dynamics of the phosphatidylserine market by aligning with rising consumer demand for sustainable and ethically sourced ingredients. Traditionally, phosphatidylserine has been extracted from bovine brain or soy lecithin; however, increasing concerns regarding animal welfare, allergenicity, and environmental sustainability are propelling the shift towards plant-derived sources such as sunflower lecithin and other non-GMO crops.

Analyst Opinion (Expert Opinion)

The Phosphatidylserine market is witnessing notable traction driven primarily by rising consumer awareness regarding cognitive health and the increasing prevalence of neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease. As a critical phospholipid involved in brain function, phosphatidylserine’s role in enhancing memory, focus, and overall cognitive performance continues to fuel demand across dietary supplements and functional food sectors. Additionally, the growing aging population globally further bolsters market growth, with both elderly consumers and middle-aged individuals seeking preventive cognitive health solutions.

However, market expansion faces certain restraints, including stringent regulatory frameworks concerning novel food ingredients and supplements, which can delay product approvals and limit market entry for new players. Furthermore, variability in raw material sourcing, often derived from soy or bovine cortex, poses challenges related to sustainability and consistent quality, potentially impacting supply chains.

Opportunities exist in the development of plant-based and non-GMO phosphatidylserine products aligned with shifting consumer preferences toward natural and organic ingredients. Emerging markets, especially in the Asia-Pacific region, are exhibiting rapid adoption owing to increasing disposable incomes and growing awareness about brain health supplements. North America and Europe continue to dominate the market, attributed to high consumer spending power and well-established distribution channels.

Global Phosphatidylserine Market: Key Developments

  • In March 2026, Mannatech Korea announced a new product called ‘Brain Plus’. The product is designed to help the brain work better and reduce stress. It focuses on preventing memory and thinking problems that can come with age and lowering tension caused by stress.
  • In 2025, ECA Healthcare launched SunPS, a phosphatidylserine (PS) made from sunflowers to support memory, focus, and reduce stress. It contains 70–80% PS, mixes well, and flows easily. The product is allergen-free, soy-free, non-GMO, and safe for use in dietary supplements, functional foods, and brain health products.

Market Segmentation

  • By Nature
    • Organic
    • Conventional
  • By Source
    • Meat
    • Fish
    • Plants
  • By Forms
    • Powder
    • Liquid
    • Capsule
  • By Distribution Channel
    • Online
    • Offline
  • By Application
    • Functional Food
    • Medical Food
    • Dietary Supplements
    • Others
  • By Region
    • North America
      • U.S.
      • Canada
    • Latin America
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
    • Europe
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East & Africa
      • GCC Countries
      • Israel
      • Rest of Middle East & Africa
  • Key Players
    • Solgar Inc.
    • Nature’s Way Products Llc.
    • Wuhan Demekai biotechnology Co. ltd.
    • Jarrow Formulas Inc
    • Lipoid Gmbh, Lipogen Products Ltd.
    • Double Wood Llc.
    • Xi’an Sino Herb Bio-Technology Co. Ltd.
    • Xian Natural Field Bio- Technique Co. Ltd.
    • N J Chsoyue Pharm Co. Ltd.
    • Swanson Health Products Inc.
    • ECA Healthcare Inc.
    • IvoVital Gmbh.

Sources

Primary Research Interviews

  • Phosphatidylserine manufacturers and suppliers
  • Dietary supplement industry executives
  • Nutraceutical product developers
  • Healthcare professionals and nutritionists
  • Others

Databases

  • Euromonitor International
  • Others

Magazines

  • Nutraceuticals World
  • Natural Products Insider
  • Food & Nutrition Magazine
  • Supplement Business Report
  • Others

Journals

  • Journal of Nutritional Science
  • Nutrients Journal
  • Food & Function Journal
  • Others

Newspapers

  • The Wall Street Journal
  • Financial Times
  • Bloomberg News
  • Food Navigator
  • Nutraingredients
  • Others

Associations

  • Council for Responsible Nutrition (CRN)
  • International Alliance of Dietary/Food Supplement Associations (IADSA)
  • Natural Products Association (NPA)
  • European Food Safety Authority (EFSA)
  • Others

Public Domain Sources

  • U.S. Food and Drug Administration (FDA)
  • European Medicines Agency (EMA)
  • World Health Organization (WHO)
  • National Institutes of Health (NIH)
  • Others

Proprietary Elements

  • CMI Data Analytics Tool
  • Proprietary CMI Existing Repository of Information for the Last 8 Years

Share

Share

Missing comfort of reading report in your local language? Find your preferred language :

Frequently Asked Questions

The global phosphatidylserine market size was valued at USD 178.4 Mn in 2026 and is expected to reach USD 271.8 Mn in 2033.

Major players operating in the market include Solgar Inc., Nature’s Way Products Llc., Wuhan Demekai biotechnology Co. ltd., Jarrow Formulas Inc, Lipoid Gmbh, Lipogen Products Ltd., Double Wood Llc., Xi’an Sino Herb Bio-Technology Co. Ltd., Xian Natural Field Bio- Technique Co. Ltd., N J Chsoyue Pharm Co. Ltd., Swanson Health Products Inc., ECA Healthcare Inc., and IvoVital Gmbh.

Among nature, the conventional segment estimated significant revenue in 2026.

Growing demand for functional foods and dietary supplements is expected to drive the market growth of global phosphatidylserine during the forecast period.

The market is estimated to exhibit a CAGR of 6.5% till 2033.

Among region, Asia Pacific is expected to witness significant growth over the forecast period.

Select a License Type

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2026 Coherent Market Insights Pvt Ltd. All Rights Reserved.